tiprankstipranks
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
Holding ACAD?
Track your performance easily

ACADIA Pharmaceuticals (ACAD) Income Statement

2,260 Followers

ACADIA Pharmaceuticals Income Statement

Last quarter (Q3 2024), ACADIA Pharmaceuticals's total revenue was $250.40M, an increase of 18.28% from the same quarter last year. In Q3, ACADIA Pharmaceuticals's net income was $32.77M. See ACADIA Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 929.24M$ 726.44M$ 517.24M$ 484.14M$ 441.75M$ 339.08M
Cost of Revenue
$ 77.93M$ 41.64M$ 10.17M$ 19.14M$ 20.55M$ 11.34M
Gross Profit
$ 851.31M$ 684.80M$ 507.07M$ 465.00M$ 421.20M$ 327.73M
Operating Expense
$ 739.07M$ 758.18M$ 730.66M$ 635.44M$ 707.79M$ 566.02M
Operating Income
$ 112.23M$ -73.38M$ -223.60M$ -170.44M$ -286.59M$ -246.54M
Net Non Operating Interest Income Expense
$ 23.21M$ 17.23M$ 6.61M$ 591.00K$ 6.61M$ 11.16M
Other Income Expense
$ 8.97M$ 5.11M$ 3.54M$ -2.33M$ 997.00K$ -997.00K
Pretax Income
$ 136.70M$ -51.04M$ -213.44M$ -167.52M$ -280.97M$ -234.38M
Tax Provision
$ 8.11M$ 10.25M$ 2.53M$ 351.00K$ 611.00K$ 876.00K
Earnings From Equity Interest Net Of Tax
$ -51.04M$ -51.04M$ -213.44M$ -167.52M$ -280.97M-
Net Income Common Stockholders
$ 128.47M$ -61.29M$ -215.97M$ -167.87M$ -281.58M$ -218.75M
Basic EPS
$ 0.79$ -0.37$ -1.34$ -1.05$ -1.79$ -1.60
Diluted EPS
$ 0.79$ -0.37$ -1.34$ -1.05$ -1.79$ -1.60
Basic Average Shares
$ 496.32M$ 163.82K$ 161.68K$ 160.49M$ 157.33M$ 147.20M
Diluted Average Shares
$ 498.98M$ 163.82K$ 161.68K$ 160.49M$ 157.33M$ 147.20M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 817.00M$ 799.82M$ 740.83M$ 646.29M$ 718.00M$ 577.37M
Net Income From Continuing And Discontinued Operation
$ 128.51M$ -61.29M$ -215.97M$ -167.87M$ -281.58M$ -235.26M
Normalized Income
$ 96.03M-----
Interest Expense
------
EBIT
$ 131.90M$ -73.38M$ -223.60M$ -170.44M$ -286.59M$ -234.38M
EBITDA
$ 144.21M$ -67.83M$ -221.57M$ -167.09M$ -283.65M$ -235.20M
Currency in USD

ACADIA Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis